| Weathering the cytokine storm in susceptible patients with severe SARS-CoV-2 infection B Lipworth, R Chan, S Lipworth, CRW Kuo The Journal of Allergy and Clinical Immunology: In Practice 8 (6), 1798-1801, 2020 | 66 | 2020 |
| Scottish consensus statement on the role of FeNO in adult asthma CRW Kuo, M Spears, J Haughney, A Smith, J Miller, T Bradshaw, ... Respiratory medicine 155, 54-57, 2019 | 53 | 2019 |
| Pragmatic clinical perspective on biologics for severe refractory type 2 asthma R Chan, CRW Kuo, B Lipworth The Journal of Allergy and Clinical Immunology: In Practice 8 (10), 3363-3370, 2020 | 40 | 2020 |
| Disconnect between effects of mepolizumab on severe eosinophilic asthma and chronic rhinosinusitis with nasal polyps R Chan, CRW Kuo, B Lipworth The Journal of Allergy and Clinical Immunology: In Practice 8 (5), 1714-1716, 2020 | 35 | 2020 |
| Current appraisal of single inhaler triple therapy in COPD B Lipworth, CRW Kuo, S Jabbal International Journal of Chronic Obstructive Pulmonary Disease, 3003-3009, 2018 | 31 | 2018 |
| I say IOS you say AOS: comparative bias in respiratory impedance measurements CRW Kuo, S Jabbal, B Lipworth Lung 197, 473-481, 2019 | 30 | 2019 |
| Is small airways dysfunction related to asthma control and type 2 inflammation? CRW Kuo, S Jabbal, B Lipworth Annals of Allergy, Asthma & Immunology 121 (5), 631-632, 2018 | 28 | 2018 |
| 2020 updated asthma guidelines: clinical utility of fractional exhaled nitric oxide (Feno) in asthma management B Lipworth, CRW Kuo, R Chan Journal of Allergy and Clinical Immunology 146 (6), 1281-1282, 2020 | 23 | 2020 |
| Predicting severe outcomes in COVID-19 B Lipworth, R Chan, CR Kuo The Journal of Allergy and Clinical Immunology: In Practice 8 (8), 2582-2584, 2020 | 18 | 2020 |
| Randomized controlled trial of triple versus dual inhaler therapy on small airways in smoking asthmatics S Jabbal, CRW Kuo, B Lipworth Clinical & Experimental Allergy 50 (10), 1140-1147, 2020 | 17 | 2020 |
| Inhaled corticosteroids and COVID-19 B Lipworth, CRW Kuo, S Lipworth, R Chan American Journal of Respiratory and Critical Care Medicine 202 (6), 899-900, 2020 | 17 | 2020 |
| Real-life small airway outcomes in severe asthma patients receiving biologic therapies R Chan, CRW Kuo, B Lipworth The Journal of Allergy and Clinical Immunology: In Practice 9 (7), 2907-2909, 2021 | 16 | 2021 |
| COVID-19: Start with the nose B Lipworth, R Chan, CRW Kuo Journal of Allergy and Clinical Immunology 146 (5), 1214, 2020 | 15 | 2020 |
| Impulse oscillometry bronchodilator response and asthma control CRW Kuo, R Chan, B Lipworth The Journal of Allergy and Clinical Immunology: In Practice 8 (10), 3610-3612, 2020 | 15 | 2020 |
| Anti-inflammatory reliever therapy for asthma B Lipworth, R Chan, CRW Kuo Annals of Allergy, Asthma & Immunology 124 (1), 13-15, 2020 | 15 | 2020 |
| Eosinophil depletion with benralizumab is associated with attenuated mannitol airway hyperresponsiveness in severe uncontrolled eosinophilic asthma R Chan, CRW Kuo, S Jabbal, BJ Lipworth Journal of Allergy and Clinical Immunology 151 (3), 700-705. e10, 2023 | 14 | 2023 |
| Systemic IL-6 and severe asthma B Lipworth, R Chan, C Kuo American journal of respiratory and critical care medicine 202 (9), 1324-1325, 2020 | 12 | 2020 |
| Use of inhaled corticosteroids in asthma and coronavirus disease 2019: keep calm and carry on B Lipworth, R Chan, CRW Kuo Annals of Allergy, Asthma & Immunology 125 (5), 503-504, 2020 | 12 | 2020 |
| Emerging pharmacotherapy for COVID-19 B Lipworth, CRW Kuo, R Chan Journal of the Royal College of Physicians of Edinburgh 50 (2), 133-137, 2020 | 12 | 2020 |
| Does unified allergic airway disease impact on lung function and type 2 biomarkers? CRW Kuo, R Chan, B Lipworth Allergy, Asthma & Clinical Immunology 15 (1), 75, 2019 | 11 | 2019 |
